Transcatheter aortic valve implantation against conventional aortic valve replacement surgery in high-risk patients with aortic stenosis; a cost-effectiveness analysis

Table 4 base case analysis of the cost-effectiveness of TAVI vs SAVR

	Costs (I.R.I Rials)	QALYs	Incremental Cost	Incremental QALYs	ICER
TAVI	720,257,876 (US$ 2,881)	1.27	368,180,101 (US$ 1,473)	0.37	995,081,354 (US$ 3,980)
SAVR	352,077,775 (US$ 1,408)	0.90	–-	–-	–-

ISSN: 2191-1991